←Back to structures
BML_coassembly_scaffold_172_curated_closed_complete_prodigal-single.1__X__X__00054
Bact-VirBML_coassembly_scaffold_172_curated_closed_complete_prodigal-single.1__X__X__00054
Identity
- Kingdom:
- phage
Quality
82.2
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 31-156
Domain cluster:
representative
CATH (37)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ebkB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.77 | 62.0 | 5.58e-01 | 100.0% | 64.0% |
| 2cm4A00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.75 | 59.0 | 5.58e-01 | 100.0% | 71.0% |
| 3f6zB01 | 2.40.128.200 | Mainly Beta › Beta Barrel › Lipocalin › C-type lysozyme inhibitor | 0.73 | 45.0 | 5.51e-01 | 96.8% | 97.5% |
| 3brnB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.71 | 55.0 | 5.19e-01 | 100.0% | 68.9% |
| 1qwdB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.70 | 58.0 | 5.20e-01 | 100.0% | 65.1% |
| 3l4rA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.69 | 57.0 | 5.37e-01 | 100.0% | 73.5% |
| 4oddA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.69 | 56.0 | 5.35e-01 | 100.0% | 74.5% |
| 1e5pA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.68 | 56.0 | 5.35e-01 | 100.0% | 75.2% |
| 2qmiA02 | 2.40.128.210 | Mainly Beta › Beta Barrel › Lipocalin › Pab87 octamerisation domain | 0.68 | 47.0 | 5.13e-01 | 99.2% | 89.0% |
| 1dzkA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.67 | 56.0 | 5.28e-01 | 99.2% | 75.0% |
| 1ew3A00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.67 | 56.0 | 5.17e-01 | 100.0% | 70.4% |
| 4wfvA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.67 | 55.0 | 5.20e-01 | 100.0% | 72.5% |
| 2ra6C00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.67 | 54.0 | 5.17e-01 | 97.6% | 75.5% |
| 4kc7A02 | 2.40.128.10 | Mainly Beta › Beta Barrel › Lipocalin › | 0.64 | 47.0 | 5.21e-01 | 100.0% | 98.0% |
| 2vdfA00 | 2.40.128.100 | Mainly Beta › Beta Barrel › Lipocalin › OPCA outer membrane adhesin/invasin | 0.61 | 55.0 | 4.55e-01 | 99.2% | 98.7% |
| 4jglA00 | 2.40.128.530 | Mainly Beta › Beta Barrel › Lipocalin › | 0.60 | 55.0 | 5.16e-01 | 99.2% | 82.2% |
| 1vprA03 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.60 | 54.0 | 5.02e-01 | 100.0% | 96.8% |
| 2lfuA02 | 2.40.160.90 | Mainly Beta › Beta Barrel › Porin › | 0.58 | 48.0 | 4.84e-01 | 100.0% | 89.1% |
| 3d9wA02 | 2.40.128.150 | Mainly Beta › Beta Barrel › Lipocalin › Cysteine proteinases | 0.58 | 43.0 | 4.66e-01 | 96.8% | 97.1% |
| 2o62A01 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.58 | 51.0 | 5.09e-01 | 100.0% | 90.8% |
| 3p51A00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.57 | 42.0 | 4.00e-01 | 84.1% | 66.2% |
| 2flhB00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.56 | 45.0 | 4.17e-01 | 86.5% | 68.0% |
| 2o62A02 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.56 | 52.0 | 5.07e-01 | 100.0% | 94.9% |
| 2fwvA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.56 | 50.0 | 4.40e-01 | 100.0% | 66.3% |
| 1fm4A00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.56 | 44.0 | 4.05e-01 | 86.5% | 65.4% |
| 1lfoA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.55 | 51.0 | 5.12e-01 | 100.0% | 99.2% |
| 1p6pA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.54 | 49.0 | 5.00e-01 | 98.4% | 99.2% |
| 2fmlA02 | 3.90.79.10 | Alpha Beta › Alpha-Beta Complex › Nucleoside Triphosphate Pyrophosphohydrolase › Nucleoside Triphosphate Pyrophosphohydrolase | 0.54 | 39.0 | 3.56e-01 | 74.6% | 89.0% |
| 3mh9A00 | 2.50.20.20 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.53 | 47.0 | 4.04e-01 | 98.4% | 90.7% |
| 1mdcA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.53 | 48.0 | 4.73e-01 | 98.4% | 100.0% |
| 1ealA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.52 | 47.0 | 4.78e-01 | 100.0% | 100.0% |
| 1bt9A00 | 2.40.160.10 | Mainly Beta › Beta Barrel › Porin › Porin | 0.52 | 45.0 | 3.30e-01 | 93.7% | 94.7% |
| 3p0lD00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.52 | 42.0 | 3.76e-01 | 89.7% | 77.3% |
| 3u2gA02 | 2.60.98.40 | Mainly Beta › Sandwich › Tick-borne Encephalitis virus Glycoprotein; domain 1 › DU1608 C-terminal domain | 0.51 | 37.0 | 3.71e-01 | 85.7% | 74.4% |
| 3w9kA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.50 | 41.0 | 4.06e-01 | 100.0% | 83.0% |
| 4qa8A00 | 2.50.20.20 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.50 | 45.0 | 3.82e-01 | 100.0% | 89.5% |
| 3cnwA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.50 | 42.0 | 4.08e-01 | 100.0% | 81.6% |
ECOD (40)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 1292982 | 9.1.1.5 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Triabin | 0.77 | 62.0 | 5.46e-01 | 100.0% | 60.3% |
| 3763572 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.72 | 58.0 | 5.41e-01 | 100.0% | 69.0% |
| 3854099 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.69 | 57.0 | 5.33e-01 | 100.0% | 71.6% |
| 3844176 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.69 | 57.0 | 5.34e-01 | 100.0% | 72.5% |
| 4671100 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.69 | 57.0 | 5.35e-01 | 100.0% | 72.3% |
| 3776069 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.69 | 57.0 | 5.28e-01 | 100.0% | 70.0% |
| 5032559 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.69 | 47.0 | 5.45e-01 | 95.2% | 98.9% |
| 4449665 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.68 | 56.0 | 5.21e-01 | 100.0% | 69.4% |
| 1294396 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.68 | 57.0 | 5.34e-01 | 100.0% | 73.7% |
| 3868039 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.68 | 57.0 | 5.32e-01 | 100.0% | 73.9% |
| 3748074 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.68 | 56.0 | 5.18e-01 | 100.0% | 70.0% |
| 4380184 | 9.11.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › YdhA-like › YdhA-like › MliC | 0.68 | 47.0 | 5.41e-01 | 96.0% | 100.0% |
| 2875609 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.67 | 55.0 | 5.21e-01 | 98.4% | 74.1% |
| 4062537 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.67 | 55.0 | 5.18e-01 | 100.0% | 71.6% |
| 1684916 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.67 | 55.0 | 5.20e-01 | 100.0% | 72.5% |
| 4559690 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.66 | 55.0 | 5.05e-01 | 100.0% | 69.4% |
| 3664762 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.66 | 62.0 | 5.49e-01 | 100.0% | 74.9% |
| 4928853 | 9.1.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › META | 0.66 | 56.0 | 5.88e-01 | 97.6% | 98.3% |
| 3735466 | 331.3.1.0 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like | 0.61 | 46.0 | 4.13e-01 | 86.5% | 58.2% |
| 224086 | 9.18.1.0 ↗ | beta barrels › Lipocalins/Streptavidin | 0.60 | 55.0 | 5.16e-01 | 99.2% | 82.2% |
| 3838496 | 5084.1.1.15 ↗ | beta barrels › Outer membrane meander beta-barrels › OMPA-like › OMPA-like › HP_OMP | 0.60 | 54.0 | 4.40e-01 | 96.8% | 99.6% |
| 3335226 | 331.3.1.1 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Bet_v_1 | 0.60 | 45.0 | 3.96e-01 | 86.5% | 54.3% |
| 3293351 | 331.3.1.1 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Bet_v_1 | 0.59 | 45.0 | 4.69e-01 | 86.5% | 84.2% |
| 4951886 | 3174.4.1.0 ↗ | beta barrels › Ribosomal protein L14-like › Hypothetical protein NegoA.19184.a N-terminal domain › Hypothetical protein NegoA.19184.a N-terminal domain | 0.58 | 33.0 | 3.80e-01 | 100.0% | 76.7% |
| 3624142 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.58 | 54.0 | 5.25e-01 | 100.0% | 96.4% |
| 183289 | 5084.1.1.1 ↗ | beta barrels › Outer membrane meander beta-barrels › OMPA-like › OMPA-like › TbpB_B_D | 0.58 | 48.0 | 4.58e-01 | 100.0% | 75.7% |
| 3931011 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.58 | 53.0 | 5.26e-01 | 100.0% | 94.6% |
| 4346133 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.57 | 53.0 | 5.06e-01 | 100.0% | 97.2% |
| 2320506 | 9.1.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins | 0.57 | 52.0 | 5.01e-01 | 100.0% | 95.8% |
| 3942181 | 6150.1.1.0 ↗ | a+b two layers › hypotheical protein Lreu_0056 › hypotheical protein Lreu_0056 › hypotheical protein Lreu_0056 | 0.56 | 44.0 | 4.77e-01 | 98.4% | 100.0% |
| 3032876 | 331.3.1.1 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Bet_v_1 | 0.55 | 45.0 | 4.14e-01 | 88.1% | 66.7% |
| 3639374 | 5.1.4.1 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › WD40 | 0.55 | 35.0 | 2.61e-01 | 88.9% | 24.8% |
| 818 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.54 | 49.0 | 4.88e-01 | 98.4% | 99.2% |
| 3293543 | 331.3.1.11 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc2 | 0.53 | 42.0 | 3.90e-01 | 86.5% | 66.9% |
| 3271407 | 4.1.1.0 ↗ | beta barrels › SH3 › SH3 › SH3 | 0.53 | 29.0 | 3.40e-01 | 100.0% | 77.6% |
| 4331031 | 331.3.1.11 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc2 | 0.52 | 46.0 | 4.35e-01 | 100.0% | 78.7% |
| 6330 | 331.3.1.11 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc2 | 0.51 | 42.0 | 4.12e-01 | 98.4% | 82.6% |
| 3225093 | 10.1.1.4 ↗ | beta sandwiches › jelly-roll › Concanavalin A-like › Concanavalin A-like lectins/glucanases › Gal-bind_lectin | 0.50 | 39.0 | 3.73e-01 | 100.0% | 70.0% |
| 3412495 | 220.1.1.85 ↗ | beta barrels › PH domain-like › PH domain-like › PH domain-like › PID_2 | 0.50 | 39.0 | 3.65e-01 | 100.0% | 64.2% |
| 1401858 | 71.1.1.6 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › LppX_LprAFG | 0.50 | 45.0 | 3.82e-01 | 100.0% | 89.5% |